onr:"swepub:oai:DiVA.org:uu-108752"
Search: onr:"swepub:oai:DiVA.org:uu-108752" > New perspectives in...
- 1 of 1
- Previous record
- Next record
- To hitlist
New perspectives in managing myeloproliferative disorders : focus on the patient
-
- Birgegård, Gunnar, 1944- (author)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Hematologi
- (creator_code:org_t)
- 2009-05-25
- 2009
- English.
- In: Hematological Oncology. - : Wiley. - 0278-0232 .- 1099-1069. ; 27:Suppl.1, s. 5-7
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Risk stratification is the basis for treatment decisions in the chronic myeloproliferative disorders, and in addition to the three established risk factors of previous thrombosis, age and platelets >1500 x 10(9), cardiovascular risk factors should be addressed. In addition, premorbidity with regard to possible side effects of platelet-reducing drugs as well as the impact on quality of life of such side effects should be considered. The near-to-normal life expectancy and long term nature of treatment also makes it necessary to consider the potential leukaemogenic effects of some cytostatic drugs.
Keyword
- MEDICINE
- MEDICIN
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Hematological Oncology (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Birgegård, Gunna ...
- Articles in the publication
- Hematological On ...
- By the university
- Uppsala University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
